Stanley Black & Decker (NYSE:SWK) issued an update on its FY18 earnings guidance on Friday morning. The company provided EPS guidance of $8.30-8.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.44.
NYSE:SWK opened at $150.01 on Friday. Stanley Black &am
This summer, Todd Hagopian and Jason Spatafora told us that traditional Biotech companies are looking at Cannabis-based Biotech stocks as buyout candidates. Since then, the four stocks they recommended are up on average 20%, while the S&P 500 is up less than 2%. We welcome them again to discuss the election and the prospects for the Marijuana stock sector.
Wednesday was a strong day for the stock market, as the Dow finished up nearly 100 points and the S&P 500 and Nasdaq both posted gains as well. Investors remained generally upbeat about the prospects for the U.S. economy in 2017, and a rise in crude oil prices helped lift the energy sector higher during the market session. Yet comments during a press conference from President-elect Donald Trump....More>>>
Shares of Foster City, California-based, biotech major, Gilead Sciences, Inc(NASDAQ:GILD) have been on a consistent decline in the last one year or so. After being one of the best performers in the biotech space since 2012, Gilead stock has lost more than 12% in last one year, while theNasdaq Composite (INDX:COMPX) has gained by more than 24% in the same period, resulting in....More>>>
Oil futures set off on a positive start Monday as the first decline in U.S. oil-drilling activity since January gave the market a fresh tailwind after seven-consecutive sessions of price gains.
The drop in Baker Hughes weekly count, coming after a record 23-straight weeks of rising numbers of active rigs, helped stoke sentiment that shale producers may have hit a bottleneck amid prolonged....More>>>